Published October 12, 2012 by LawsuitInformation.org
In recent news regarding Bayer Pharmaceuticals, the German pharmaceutical giant responsible for the manufacture of Yaz and Yasmin, the Federal Trade Commission made the decision to terminate its investigation into a patent settlement between Bayer and Teva Pharmaceuticals.
In 2008, the two pharmaceutical companies reached an agreement in regards to Bayer’s claim that Barr Laboratories, which was ultimately purchased by Teva Pharmaceuticals, overstepped the boundaries of intellectual property protecting Bayer’s Yasmin patent. The 2008 settlement drew the attention of the FTC, and led to a four year investigation into the settlement agreement’s possible antitrust violations.
Though the investigation has ended, Bayer Pharmaceuticals is still tied up in a Multi-District Litigation in the Southern District of Illinois regarding a large number of Yaz and Yasmin lawsuits.
The U.S. Food and Drug Administration released data last October 2011 regarding a Yaz and Yasmin study they conducted in order to determine the drug’s link to the development of blood clots in women. The FDA’s research indicated that among the approximately 800,000 women, they recorded an increased risk of suffering from the development of a blood clot.
It is believed that the chemical drospirenone, which is present in both Yaz and Yasmin, causes health complications in women. The presence of drospirenone in the body elevates levels of potassium, and thus, puts women at a higher risk of developing a blood clot.
Yaz and Yasmin side effects include:
Deep Vein Thrombosis is a serious health condition in which a blood clot forms in a deep vein, most often in a vein in the leg. DVT has been known to cause extreme pain in the location of the blood clot. The danger of DVT is the blood clot migrating to the lungs or brain, causing a more serious and life-threatening condition.
Pulmonary Embolism occurs when a blood clot enters an artery in the lungs, thus obstructing the normal flow of blood to the lungs, and resulting in a lack of oxygen delivery throughout the entire body.
If you or a loved one has suffered from a blood clot caused by the use of either Yaz or Yasmin, you may be eligible to receive compensation for your suffering. To file a Yaz lawsuit or a Yasmin lawsuit, contact our experienced pharmaceutical litigation lawyers at Carey Danis & Lowe.References: Pharmaceutical litigation, Yaz/Yasmin